Quels sont les principaux facteurs de risque pour le cancer pelvien ?
Les facteurs incluent l'âge, le tabagisme, des antécédents familiaux et certaines infections.
Facteurs de risqueCancerTabagisme
#2
Comment les infections sexuellement transmissibles influencent-elles le risque ?
Certaines infections, comme le HPV, augmentent le risque de cancers pelviens, notamment le col de l'utérus.
Infections sexuellement transmissiblesHPVCancer du col de l'utérus
#3
Le mode de vie peut-il affecter le risque de cancer pelvien ?
Oui, un mode de vie sain, incluant une alimentation équilibrée et l'exercice, peut réduire le risque.
Mode de vieAlimentationExercice physique
#4
Les antécédents familiaux jouent-ils un rôle dans le risque ?
Oui, des antécédents familiaux de cancer pelvien peuvent augmenter le risque individuel.
Antécédents familiauxCancerFacteurs génétiques
#5
Quel est l'impact de l'âge sur le risque de cancer pelvien ?
Le risque de cancer pelvien augmente avec l'âge, surtout après 50 ans.
ÂgeCancerRisque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Exentération pelvienne : Questions médicales les plus fréquentes",
"headline": "Exentération pelvienne : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Exentération pelvienne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-07",
"dateModified": "2026-08-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Exentération pelvienne"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Procédures de chirurgie opératoire",
"url": "https://questionsmedicales.fr/mesh/D013514",
"about": {
"@type": "MedicalCondition",
"name": "Procédures de chirurgie opératoire",
"code": {
"@type": "MedicalCode",
"code": "D013514",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Exentération pelvienne",
"alternateName": "Pelvic Exenteration",
"code": {
"@type": "MedicalCode",
"code": "D010385",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Michael J Solomon",
"url": "https://questionsmedicales.fr/author/Michael%20J%20Solomon",
"affiliation": {
"@type": "Organization",
"name": "Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, Australia; Faculty of Medicine and Health, Central Clinical School, The University of Sydney, New South Wales, Australia. Electronic address: professor.solomon@sydney.edu.au."
}
},
{
"@type": "Person",
"name": "Daniel Steffens",
"url": "https://questionsmedicales.fr/author/Daniel%20Steffens",
"affiliation": {
"@type": "Organization",
"name": "Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Camperdown, NSW, Australia. daniel.steffens@health.nsw.gov.au."
}
},
{
"@type": "Person",
"name": "Kilian G M Brown",
"url": "https://questionsmedicales.fr/author/Kilian%20G%20M%20Brown",
"affiliation": {
"@type": "Organization",
"name": "Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Camperdown, NSW, Australia."
}
},
{
"@type": "Person",
"name": "Björn Lampe",
"url": "https://questionsmedicales.fr/author/Bj%C3%B6rn%20Lampe",
"affiliation": {
"@type": "Organization",
"name": "Department of Gynecology & Obstetrics, Florence Nightingale Hospital, Kreuzbergstr. 79, 40489 Düsseldorf, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Pelvic exenteration for chronic fistulating pelvic sepsis after multimodal treatment of pelvic malignancy.",
"datePublished": "2023-10-20",
"url": "https://questionsmedicales.fr/article/37879161",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejso.2023.107124"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Pelvic Exenteration - Is it worth taking on greater risk?]",
"datePublished": "2024-09-30",
"url": "https://questionsmedicales.fr/article/39348202",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1556/1046.2024.30001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Modular Pelvic Exenteration for Advanced Rectal Cancer in Frozen Pelvis.",
"datePublished": "2023-11-16",
"url": "https://questionsmedicales.fr/article/37968899",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12659/AJCR.941684"
}
},
{
"@type": "ScholarlyArticle",
"name": "Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies.",
"datePublished": "2023-10-25",
"url": "https://questionsmedicales.fr/article/37878167",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10151-023-02869-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating postoperative hernia incidence and risk factors following pelvic exenteration.",
"datePublished": "2024-05-08",
"url": "https://questionsmedicales.fr/article/38717479",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00384-024-04638-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Procédures de chirurgie opératoire",
"item": "https://questionsmedicales.fr/mesh/D013514"
},
{
"@type": "ListItem",
"position": 3,
"name": "Exentération pelvienne",
"item": "https://questionsmedicales.fr/mesh/D010385"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Exentération pelvienne - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Exentération pelvienne",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Exentération pelvienne",
"description": "Comment diagnostiquer un cancer nécessitant une exentération pelvienne ?\nQuels tests sont utilisés pour évaluer l'étendue de la maladie ?\nQuels symptômes peuvent indiquer un besoin d'exentération ?\nQuel rôle joue l'évaluation clinique dans le diagnostic ?\nComment les marqueurs tumoraux sont-ils utilisés dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D010385#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Exentération pelvienne",
"description": "Quels sont les symptômes courants d'un cancer pelvien avancé ?\nComment les symptômes varient-ils selon le type de cancer ?\nLes symptômes psychologiques sont-ils fréquents ?\nQuels signes indiquent une progression de la maladie ?\nComment les symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D010385#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Exentération pelvienne",
"description": "Quel est l'objectif principal de l'exentération pelvienne ?\nQuels types de traitements sont associés à l'exentération ?\nQuelles sont les alternatives à l'exentération pelvienne ?\nComment se déroule la récupération après l'exentération ?\nQuels soins post-opératoires sont nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D010385#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Exentération pelvienne",
"description": "Quelles sont les complications possibles après une exentération ?\nComment prévenir les infections post-opératoires ?\nLes complications psychologiques sont-elles fréquentes ?\nQuels signes indiquent une complication post-opératoire ?\nComment gérer les complications urinaires après l'exentération ?",
"url": "https://questionsmedicales.fr/mesh/D010385#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Exentération pelvienne",
"description": "Quels sont les principaux facteurs de risque pour le cancer pelvien ?\nComment les infections sexuellement transmissibles influencent-elles le risque ?\nLe mode de vie peut-il affecter le risque de cancer pelvien ?\nLes antécédents familiaux jouent-ils un rôle dans le risque ?\nQuel est l'impact de l'âge sur le risque de cancer pelvien ?",
"url": "https://questionsmedicales.fr/mesh/D010385#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cancer nécessitant une exentération pelvienne ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic est établi par biopsie, imageries (IRM, scanner) et évaluation clinique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'étendue de la maladie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens d'imagerie comme le scanner et l'IRM sont utilisés pour évaluer l'étendue."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un besoin d'exentération ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs pelviennes, des saignements anormaux ou des troubles urinaires peuvent indiquer cela."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'évaluation clinique dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation clinique aide à identifier les symptômes et à orienter les examens complémentaires."
}
},
{
"@type": "Question",
"name": "Comment les marqueurs tumoraux sont-ils utilisés dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs tumoraux peuvent aider à surveiller la progression de la maladie et la réponse au traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'un cancer pelvien avancé ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs pelviennes, troubles urinaires, et saignements vaginaux."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon le type de cancer ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier; par exemple, le cancer colorectal peut causer des changements intestinaux."
}
},
{
"@type": "Question",
"name": "Les symptômes psychologiques sont-ils fréquents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et la dépression peuvent survenir en raison du diagnostic et du traitement."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une progression de la maladie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une augmentation des douleurs, des saignements ou des troubles fonctionnels peuvent indiquer une progression."
}
},
{
"@type": "Question",
"name": "Comment les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent gravement affecter la qualité de vie, rendant les activités quotidiennes difficiles."
}
},
{
"@type": "Question",
"name": "Quel est l'objectif principal de l'exentération pelvienne ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'objectif est d'éliminer complètement la tumeur et de prévenir la récidive du cancer."
}
},
{
"@type": "Question",
"name": "Quels types de traitements sont associés à l'exentération ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chimiothérapie et la radiothérapie peuvent être utilisées avant ou après l'exentération."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives à l'exentération pelvienne ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les alternatives incluent la chirurgie conservatrice, la radiothérapie ou des traitements palliatifs."
}
},
{
"@type": "Question",
"name": "Comment se déroule la récupération après l'exentération ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La récupération peut prendre plusieurs semaines et nécessite un suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Quels soins post-opératoires sont nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins incluent la gestion de la douleur, la surveillance des infections et la rééducation."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles après une exentération ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure infections, hémorragies et problèmes urinaires ou intestinaux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections post-opératoires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'utilisation d'antibiotiques prophylactiques et des soins de plaies appropriés."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles fréquentes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications psychologiques comme l'anxiété et la dépression peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication post-opératoire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une douleur accrue, de la fièvre ou des saignements anormaux doivent alerter."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications urinaires après l'exentération ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion peut inclure des cathéters, des médicaments et une rééducation pelvienne."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour le cancer pelvien ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le tabagisme, des antécédents familiaux et certaines infections."
}
},
{
"@type": "Question",
"name": "Comment les infections sexuellement transmissibles influencent-elles le risque ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections, comme le HPV, augmentent le risque de cancers pelviens, notamment le col de l'utérus."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter le risque de cancer pelvien ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant une alimentation équilibrée et l'exercice, peut réduire le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle dans le risque ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer pelvien peuvent augmenter le risque individuel."
}
},
{
"@type": "Question",
"name": "Quel est l'impact de l'âge sur le risque de cancer pelvien ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de cancer pelvien augmente avec l'âge, surtout après 50 ans."
}
}
]
}
]
}
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2019-06-14
Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, Australia; Faculty of Medicine and Health, Central Clinical School, The University of Sydney, New South Wales, Australia. Electronic address: professor.solomon@sydney.edu.au.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2023-10-20
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2024-05-07
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2021-07-27
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2021-07-27
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2021-04-17
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2023-10-20
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2024-05-07
Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, Australia.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2023-10-20
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2024-05-07
Surgical Outcomes Research Centre (SOuRCe), University of Sydney & Sydney Local Health District, New South Wales, Australia; The Institute of Academic Surgery at RPA, Sydney Local Health District, Sydney, New South Wales, Australia; Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2021-07-27
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2021-04-17
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2022-11-03
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, 400012, India; Homi Bhabha National Institute, Mumbai, 400012, India. Electronic address: asaklani@hotmail.com.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2022-11-03
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2024-10-13
Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.
Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany.
Chronic fistulating pelvic sepsis is an uncommon complication of multimodal treatment of visceral pelvic tumours. Radical multi-visceral resection is reserved for patients with persistent, debilitatin...
This retrospective cohort study was conducted at a high-volume pelvic exenteration referral centre. Patients who underwent pelvic exenteration for chronic fistulating pelvic sepsis between September 1...
19 patients who underwent radical resection for chronic fistulating pelvic sepsis after previous pelvic cancer treatment were included. 11 patients were male (58 %) and median age was 62 years (range ...
Pelvic exenteration for refractory pelvic sepsis following treatment of malignancy is safe and effective in selected patients....
A lokálisan előrehaladott vagy recidív kismedencei daganatok kezelésére a totális (TPE) vagy parciális kismedencei exenteráció (PPE) lehet az egyetlen kuratív műtét, mely a beteg túlélését növelheti. ...
Retrospektív módon elemeztük az osztályunkon 2016. 09. 01. és 2022. 10. 31. között végzett kismedencei exenteráció (PE) műtéti adatait a morbiditás, mortalitás, specimenhisztológia tekintetében. Az él...
32 betegen történt PE. 20 (62,5%) volt nő és 12 (37,5%) férfi. A medián életkor 60 év volt (41-82 év, IQR: 13). 7 műtét laparoszkópos (21,8%) és 25 nyitott módon történt (78,2%). 27 esetben (84,3%) pr...
A kezdetben palliatív műtétként végzett beavatkozás kuratívvá vált. A radioterápia növeli a negatív reszekciós szél valószínűségét, ami szignifikáns prediktora a betegségmentes túlélésnek (DFS), ugyan...
BACKGROUND Surgery for locally advanced rectal cancer with frozen pelvis is challenging. Therefore, we designed the "modular pelvic exenteration" surgical strategy to achieve better radical resection....
The purpose of this study was to clarify the efficacy and safety of transanal minimally invasive surgery (TAMIS) for total pelvic exenteration (TPE) in advanced primary and recurrent pelvic malignanci...
Using a prospectively collected database, we retrospectively analyzed the clinical, surgical, and pathological outcomes of TAMIS for TPE. Surgery was performed between September 2019 and April 2023. T...
Fifteen consecutive patients were included in this analysis M:F = 14:1 and median (range) age was 63 (36-74). Their diagnoses were as follows: primary rectal cancer (n = 5; 33%), recurrent rectal canc...
The short-term outcomes of this initial experience proved that this novel approach is feasible for TPE, with low blood loss, acceptable postoperative complications, and a satisfactory R0 resection rat...
Pelvic exenteration (PE) is a technically challenging surgical procedure. More recently, quality of life and survivorship following PEs are being increasingly acknowledged as important patient outcome...
A retrospective cohort study examining hernia formation following PE for locally advanced rectal carcinoma and locally recurrent rectal carcinoma between June 2010 and August 2022 at a quaternary canc...
A total of 79 patients (32.5%) were identified as having developed a hernia. Expectantly, those undergoing flap reconstruction had a lower incidence of postoperative hernias. Of the 79 patients who de...
This study found over one-third of PE patients developed a hernia postoperatively. This paper highlights the importance of careful perioperative planning and optimization of patients to minimize morbi...
Information on the course of quality of life after surgery for advanced cancers within the pelvis is important to guide patient decision-making; however, the current evidence is limited....
To identify quality-of-life trajectory classes and their predictors after pelvic exenteration....
Prospective cohort study....
Highly specialized quaternary pelvic exenteration referral center....
Patients undergoing pelvic exenteration due to advanced/recurrent cancers within the pelvis between July 2008 and July 2022....
Quality-of-life data included the 36-item Short-Form Survey (physical and mental component scores) and the Functional Assessment of Cancer Therapy-Colorectal instruments, which were collected at 11 di...
The study included 565 participants. Two distinct quality-of-life trajectory classes were identified for the Physical Component Score (class 1: high stable and class 2: high decreasing). Three distinc...
This study was conducted at a single highly specialized quaternary pelvic exenteration referral center, and findings may not apply to other centers....
This study demonstrates that quality of life after pelvic exenteration diverges into distinct trajectories, with most patients reporting an optimal course. See Video Abstract ....
ANTECEDENTES:La información sobre la evolución en la calidad de vida después de cirugía en cánceres avanzados situados en la pelvis es importante para guiar la toma de decisiones sobre el paciente; si...
Large tissue defects following pelvic exenteration (PE) fill with fluid and small bowel, leading to the empty pelvis syndrome (EPS). EPS causes a constellation of complications including pelvic sepsis...
The true pelvis is defined by the pelvic inlet and outlet. Within the true pelvis there is physiological pelvic dead space (PDS) between the peritoneal reflection and the inlet. This dead space is inc...
A patient undergoing total infralevator PE had a PDS of 50 ml. A rectus flap rendered the pelvic outlet watertight. EPD was then measured as 540 ml. Therefore there was a 10.8-fold increase in true pe...
This is the first reported quantitative assessment of pathophysiological volumetric changes of pelvic dead space; these measurements may correlate to severity of EPS. PDS, EPD, and PFV should be amend...
Anal cancer incidence and mortality rates are rising in the United Kingdom (UK). Surgery is an important treatment modality for persistent or recurrent disease. There is a paucity of data on outcomes ...
A retrospective review of prospectively maintained databases from 2011 to 2020 was undertaken. Primary endpoints included R0 resection rates, overall and disease-free survival at 2 and 5 years....
From 2011 to 2020, 35 patients with anal SCC were selected for exenteration. An R0 resection was achieved in 26 patients (77%). Of the remaining patients, seven patients had an R1 resection and one ha...
Complete R0 resection for recurrent or persistent anal SCC is possible in the majority of patients and improves overall and disease-free survival compared with R1/R2 resection....
Late relapses of Wilms tumour are extremely uncommon but still represent possible events. Even more rarely Wilms tumours present as extrarenal neoplasms, for which it could be difficult to diagnose an...
Pelvic exenteration (PE) surgery is now a widely accepted procedure that is increasingly being performed worldwide but has significant morbidity. Although nutrition status, body mass index (BMI) and p...
This was a retrospective cohort study of all patients having total PE surgery at a tertiary teaching hospital from 2012 to 2021 (n = 69). Multivariable analyses were undertaken to confirm univariate a...
Patients who were malnourished according to the Subjective Global Assessment were 5.66 (OR 5.66, 95% CI 1.07-29.74, p = 0.041) times more likely to develop an infectious complication. Increasing BMI w...
Preoperative malnutrition and higher BMI were associated with complications following PE. Delay to full diet commencement was associated with increased complications and longer LOHS. Routine postopera...